ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 293, Issue 3, Pages 984-994
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2017-12-01
DOI
10.1074/jbc.m117.808584
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor
- (2017) Andrew T. Holdbrooks et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential
- (2017) Colleen M. Britain et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype
- (2016) Matthew J. Schultz et al. CANCER RESEARCH
- Prognostic and predictive markers in pancreatic adenocarcinoma
- (2016) Nha Le et al. DIGESTIVE AND LIVER DISEASE
- Importance of membrane-proximal N-glycosylation on integrin β1 in its activation and complex formation
- (2016) Sicong Hou et al. FASEB JOURNAL
- New treatment strategy with nuclear factor-κB inhibitor for pancreatic cancer
- (2016) Takashi Horiuchi et al. JOURNAL OF SURGICAL RESEARCH
- RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4
- (2016) Marie K. Kirby et al. Molecular Oncology
- SOX9 is targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA damage
- (2016) Xuehui Hong et al. NUCLEIC ACIDS RESEARCH
- Epidemiology of pancreatic cancer
- (2016) Milena Ilic et al. WORLD JOURNAL OF GASTROENTEROLOGY
- ST6Gal-I modulates docetaxel sensitivity in human hepatocarcinoma cells via the p38 MAPK/caspase pathway
- (2016) Xixi Chen et al. Oncotarget
- Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructoseresponsive manner promotes pancreatic cancer metastasis
- (2016) Chi-Che Hsieh et al. Oncotarget
- Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: Overcoming transport defects using a nanoparticle approach
- (2015) Sau Wai Hung et al. CANCER LETTERS
- Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers
- (2015) Jishun Lu et al. MOLECULES
- Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts
- (2015) Joshua A. Waters et al. SURGERY
- Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer
- (2014) Lucas de Sousa Cavalcante et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- β-Galactoside α2,6-Sialyltranferase 1 Promotes Transforming Growth Factor-β-mediated Epithelial-Mesenchymal Transition
- (2014) Jishun Lu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ABC transporters in CSCs membranes as a novel target for treating tumor relapse
- (2014) Laura Zinzi et al. Frontiers in Pharmacology
- ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells
- (2013) Matthew J Schultz et al. Journal of Ovarian Research
- A curious case of oxaliplatin-induced neurotoxicity: Recurrent, self-limiting dysarthria
- (2013) Ranjit Joseph et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells
- (2012) Jung-Jin Park et al. BIOCHEMICAL PHARMACOLOGY
- Regulation of the metastatic cell phenotype by sialylated glycans
- (2012) Matthew J. Schultz et al. CANCER AND METASTASIS REVIEWS
- Identification of Sox9-Dependent Acinar-to-Ductal Reprogramming as the Principal Mechanism for Initiation of Pancreatic Ductal Adenocarcinoma
- (2012) Janel L. Kopp et al. CANCER CELL
- Cleavage of ST6Gal I by Radiation-Induced BACE1 Inhibits Golgi-Anchored ST6Gal I-Mediated Sialylation of Integrin β1 and Migration in Colon Cancer Cells
- (2012) Minyoung Lee et al. Radiation Oncology
- Harnessing gemcitabine metabolism: a step towards personalized medicine for pancreatic cancer
- (2012) Muhammad Wasif Saif et al. Therapeutic Advances in Medical Oncology
- CNT1 Expression Influences Proliferation and Chemosensitivity in Drug-Resistant Pancreatic Cancer Cells
- (2011) Y. D. Bhutia et al. CANCER RESEARCH
- Sialylation of the Fas Death Receptor by ST6Gal-I Provides Protection against Fas-mediated Apoptosis in Colon Carcinoma Cells
- (2011) Amanda F. Swindall et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ST6Gal-I Regulates Macrophage Apoptosis via α2-6 Sialylation of the TNFR1 Death Receptor
- (2011) Zhongyu Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells
- (2011) Y.-C. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
- (2010) Ymera Pignochino et al. BMC CANCER
- Targeting AKT with the proapoptotic peptide, TAT-CTMP: A novel strategy for the treatment of human pancreatic adenocarcinoma
- (2009) Peter O. Simon et al. INTERNATIONAL JOURNAL OF CANCER
- Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells
- (2009) L. A. Parsels et al. MOLECULAR CANCER THERAPEUTICS
- The EGFR-STAT3 Oncogenic Pathway Up-regulates the Eme1 Endonuclease to Reduce DNA Damage after Topoisomerase I Inhibition
- (2008) A. Vigneron et al. CANCER RESEARCH
- Nuclear Factor- B p65/relA Silencing Induces Apoptosis and Increases Gemcitabine Effectiveness in a Subset of Pancreatic Cancer Cells
- (2008) X. Pan et al. CLINICAL CANCER RESEARCH
- Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms
- (2008) Faheem M. Shaikh et al. EXPERIMENTAL CELL RESEARCH
- ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function
- (2008) Daniel R Christie et al. Journal of Ovarian Research
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started